SensNews Apr 2017

34 / 37

Sensor100 April 2017 34
Mobidiag Completes €4M Funding Round
Finnish in vitro molecular diagnostics manufacturer Mobidiag has completed a €4.0
million ($4.3 million) funding round, the firm announced. The funding was supported
by Finnish investment service company Kansalaisrahoitus Oy.
Mobidiag currently manufactures screening tests for detection of gastrointestinal
infections, such as Clostridium difficile and bacterial gastroenteritis, as well as drug
resistant organisms, on its cartridge-based multiplex PCR and microarray instruments
— the high- to medium- volume Amplidiag platform and upcoming lower volume
Novodiag platform. Products in its pipeline include instrument and test cassettes that
take a syndromic approach, simultaneously detecting panels of bacteria, viruses, or
parasites, the firm said.
Reported by:
Abbott,Alere Move AheadWith Merger,Withdraw
Lawsuits
Abbott Laboratories has agreed to proceed with its purchase of diagnostics firmAlere
— for $500 million less than its original price offer.
Reported by: 18 April
Theranos Accused of Setting up Secret Company
Off-the-shelf machines were used to run most of its blood tests, lawsuit claims
In the ongoing saga of Theranos,, the FT reports an allegation that the company set up
a secret company, Protegic Procurement, to puchase a commercial blood analyser that
was, in fact, used to run test samples intended to induce additional investment.
Reported by: , 22 April